Escitalopram

5 trials 1 recruiting NNeurology/Psychiatry

Filter these 5 trials by condition, phase, country and more.

Open in Search →

5 Registered trials

1 Recruiting

1 Completed trials

5 Sponsors

6 Countries

Phase III

Phase II

Phase IV

Phase III: 1 Phase II: 1 Phase IV: 3

Indications tested

Anxiety disorder 1 Schizophrenia 1 Psychotic disorder 1 Depression 1

Sponsors using this IMP

Centre Hospitalier Universitaire Grenoble Alpes 1 Fundacion Para La Investigacion Biomedica Del Hospital Universitario La Paz 1 Parnassia Groep B.V. 1 Radboud Universiteit Nijmegen 1 University Medical Center Utrecht 1

All trials

5 total

A randomised, controlled trial to investigate the effect of a four/six week intensified pharmacological treatment for schizophrenia, major d… Not authorised

2022-502185-24-00 Phase III 4 countries University Medical Center Utrecht
Etude de phase II évaluant la capacité d'un agoniste des récepteurs 5-HT4, le prucalopride (Resolor©), à accélérer l'efficacité thérapeutiqu… Pending

2025-521811-38-01 Phase II 1 country Centre Hospitalier Universitaire Grenoble Alpes
Clinical trial to evaluate the effectiveness and efficiency of a pre-emptive pharmacogenetic strategy for antidepressant selection in patien… Pending

2025-522967-13-00 Phase IV 1 country Fundacion Para La Investigacion Biomedica Del Hospital Universitario La Paz
A New Intervention for Implementation of Pharmacogenetics in Psychiatry Recruiting

2023-509680-25-00 Phase IV 3 countries Parnassia Groep B.V.
Serotonin and decision-making Ended

2024-516055-41-00 Phase IV 1 country Radboud Universiteit Nijmegen

Showing 1–5 of 5 trials

← All drugs A–Z